Pages that link to "Q48509725"

The following pages link to Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy (Q48509725):

Displaying 28 items.

• Some characteristics of a peptidyl dipeptidase (kininase II) from rat CSF: differential effects of NaCl on the sequential degradation steps of bradykinin (Q28580676) (← links)
• Genetic susceptibility factors for Alzheimer's disease. (Q34134818) (← links)
• ACE variants and association with brain Aβ levels in Alzheimer's disease (Q34310258) (← links)
• No association between DCP1 genotype and late-onset Alzheimer disease. (Q34626057) (← links)
• Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping (Q34666818) (← links)
• Environmental estrogen-like chemicals and hydroxyl radicals induced by MPTP in the striatum: a review (Q34685497) (← links)
• The renin-angiotensin-aldosterone system and Alzheimer s disease? (Q35154546) (← links)
• Role of vitamin d in Parkinson's disease (Q35949729) (← links)
• The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease (Q36721915) (← links)
• Angiotensins and Alzheimer's disease: a bench to bedside overview (Q37578775) (← links)
• Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach (Q37745668) (← links)
• The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms (Q38108496) (← links)
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease. (Q38271572) (← links)
• Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain. (Q38955319) (← links)
• Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid. (Q39551996) (← links)
• Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. (Q41840991) (← links)
• Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane (Q41999193) (← links)
• Combined effects of ACE and MMP-3 polymorphisms on migraine development (Q42615455) (← links)
• Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients (Q44555817) (← links)
• Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice (Q45029150) (← links)
• Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced *OH generation in rat striatum (Q48118361) (← links)
• Detection of antigens in Alzheimer cerebrospinal fluid by monoclonal antibodies (Q48173707) (← links)
• The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis (Q48393621) (← links)
• The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease. (Q51966347) (← links)
• Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. (Q52185174) (← links)
• The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? (Q52347539) (← links)
• Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia (Q58211939) (← links)
• Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition (Q80768190) (← links)